Michelle Pusey
4Patents
0h-index
8Co-inventors
27Inventor score
Filing activity: Apr 28, 2014 → Nov 20, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11738026B2 | Combination therapy comprising an ALK2 inhibitor and a JAK2 inhibitor | Human Necessities | 0 | Active |
| US9663789B2 | PME-1 as a biomarker to predict and diagnose endometrial and breast cancer and gene silencing of PME-1 to inhibit epithelial to mesenchymal transition | Physics | 0 | Active |
| US10167472B2 | PME-1 as a biomarker to predict and diagnose an increased risk of endometrial cancer and gene silencing of PME-1 to inhibit epithelial to mesenchymal transition | Physics | 0 | Active |
| US9657349B2 | PME-1 as a biomarker to predict and diagnose an increased risk of endometrial cancer and gene silencing of PME-1 to inhibit epithelial to mesenchymal transition | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.